08:05
Audio/Slides 5G Presentation to Marin County Wireless Subcommittee
24:55
Vitamin-D: Why Does it 'Work' So Well?
16:24
Electrosmog Radiation - Effects on the VDR (and beyond)
30:57
Prof Marc Henry at UNESCO
32:37
Luc Montagnier at UNESCO, 8 Oct 2014
34:03
Prof Carlo Ventura at UNESCO
22:47
Prof Giuseppe Vitiello at UNESCO
00:31
Olmesartan in LBP of Human and Rat VDR
24:50
Prof Marshall at PPPM Summit in Moscow
04:42
Feynman explains Action of Microwave Photons
19:27
What More Is There To Discover About Vitamin-D?
21:02
Is there a role for a Tin-Foil hat in PPPM?
20:09
How Radio Waves Make You Sicker
15:20
The Microbiome in Chronic Disease Prevention
26:52
ΠΠ½Π΄ΠΎΠΌΠΈΠΊΡΠΎΠ±ΠΈΠΎΠΌ ΠΊΠ°ΠΊ ΡΡΡΠ°ΡΠ΅Π³ΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΈΠ½ΡΡΡΡΠΌΠ΅Π½ΡΠΎΠΌ Π² PPPM
26:52
Chronic Disease, the Human Microbiome, and PPPM
25:11
How the Human Microbiome causes Human Chronic Disease
14:05
Are autoantibodies the cause, or result, of autoimmune disease?
48:39
Irene Norstedt describes Horizon 2020 at the EPMA-2013 Congress
17:17
Prof Marshall at EPMA Summit in the EU-Parliament
01:35:41
St Petersburg State University - the Microbiome and Disease
01:25:05
Sarcoidosis Presentation in Kazan
10:24
FDA ALS Public Hearing
15:49
FDA's Dr Robert Temple on 'Breakthrough Therapies'
22:00
Prof. Trevor Marshall on Sarcoidosis
22:22
ΠΠΎΠΊΡΠΎΡ Π’ΡΠ΅Π²ΠΎΡ ΠΠ°ΡΡΠ°Π»Π» ΠΎ ΡΠ°ΡΠΊΠΎΠΈΠ΄ΠΎΠ·Π΅
48:47
FDA's Richard Klein on Expanded Access
35:12
Microbes and Human Disease
28:28
How the Microbiome causes Autoimmune Dysfunction
14:08
Inge Lindseth: Recovery from CFS
01:07
Olmesartan Activation of the Human VDR, but not the Rat VDR
00:14
Activation of the human VDR by Olmesartan
18:16
Psychiatric and Neurologic comorbidities as systemic dysfunctions
22:16
John Bowis, OBE, at the EPMA World Congress 2011
44:00
Dr Whitley, FDA, on Clinical Trials
32:16
Autoimmune and Neurodegenerative Disease
28:06
Prof Marshall at DNA-day 2011
19:26
'MP Vitamin D Metabolites,' Dr Greg Blaney's Porto Presentation
31:09
Prof Marshall -- Summit on Vitamin D and MS
16:36
Dr Emil Kakkis' submission to FDA Brown/Brownback hearing, June 29, 2010
06:59
Ms Mary Pendergast's submission to FDA Brown/Brownback Hearing
59:20
Archival 2006 FDA 'Visiting Professor' presentation
10:35
"Olmesartan is safe and well-tolerated at doses from 120-240mg/day"
11:41
Amy Proal on Viral and Bacterial Metagenome
23:55
Prof Marshall on vitamin D and Olmesartan
50:31
Lida Mattman at the Autoimmunity Research Foundation's Chicago Conference
11:45
Autoimmune Disease explained in 10 minutes
43:11
Amy Proal on Antibodies
43:46
Keynote Presentation at the 2008 World Gene Congress
29:32
Recovery from Autoimmune Disease - Porto Presentation
10:53
'Autoimmunity in Women', Amy Proal's Porto Presentation
11:52
'MP Study Results,' Cpt. Tom Perez's Porto Presentation
01:06:44
Chinese Language - Luzhou Medical College
X
About
The ARF is a 501(c)3 nonprofit which seeks to promulgate the pathogenesis (cause) of idiopathic inflammatory disease (including those diagnoses thought to be 'autoimmune') to physicians, and the public, worldwide.
Tags